Mankind Pharma - News
NSE: MANKIND | BSE: 543904
₹2,626.60
As on 16-Nov-2026IST
Market cap
₹1,08,424 Cr
Revenue (TTM)
₹15,379 Cr
P/E Ratio
48.3
P/B Ratio
6.2
Div. Yield
0 %
Quarterly Updates
Annual Reports
Announcements
View AnnouncementsChange In Corporate Office Address Of RTA
13-Nov-2026Intimation Regarding ESG Rating
05-Nov-2026No News & Announcements are available.